Science Daily -
13 Aug 2020 21:22
To improve our understanding of the antibody response conferring protection against HBV infection, scientists have produced and characterized human monoclonal antibodies specific to viral envelope antigens, referred as HBsAg, from blood memory B cells isolated from HBV vaccinees and natural controllers.
Share this Article
Comment on this Article
Please to comment